Asmacure

Asmacure Focuses on Developing Drugs for Inflammatory Diseases. The company's lead compound, ASM-024, has a novel multifunctional mechanism of action with both nicotinic and muscarinic effects. ASM-024 has demonstrated anti-inflammatory, bronchoprotective, and smooth muscle relaxant capabilities in preclinical asthma models.